DiscGenics Announces First Patient Treated in US Clinical Trial of IDCT for Degenerative Disc Disease

DiscGenics Announces First Patient Treated in US Clinical Trial of IDCT for Degenerative Disc Disease

IDCT is an allogeneic (donor-derived), non-invasive cell therapy comprised of proprietary Discogenic Cells and a viscous scaffold carrier. This prospective, randomized, double-blinded, vehicle- and placebo-controlled study is designed to evaluate the safety and preliminary efficacy of IDCT at varying dosage levels in subjects with single-level, symptomatic lumbar DDD, a major cause of chronic low back […]

New clinical trial shows second generation drug-eluting stents are safe and effective

New clinical trial shows second generation drug-eluting stents are safe and effective

SAN DIEGO, April 26, 2018 – Results of the PERSPECTIVE trial were presented today as late-breaking clinical science at the Society for Cardiovascular Angiography and Interventions (SCAI) 2018 Scientific Sessions. The PERSPECTIVE study is a prospective, single-center rigorously performed clinical trial and reports on one-year outcomes of patients undergoing chronic total occlusion (CTO) percutaneous coronary […]

2000 Clinical Trial Sites Now Manage eRegulatory for 600 Studies in Florence eBinders

2000 Clinical Trial Sites Now Manage eRegulatory for 600 Studies in Florence eBinders

WASHINGTON, April 26, 2018 /PRNewswire/ — Leading up to the Association of Clinical Research Professionals Annual Meeting in Washington D.C., Florence announced over 2,000 clinical trial teams are now actively managing the eRegulatory and eSource for 600+ Pharmaceutical and Medical Device studies in its eBinders solution. The leading eRegulatory and eSource solution for Clinical Trials […]

CTI Clinical Trial and Consulting Services adds 2 to clinical department

CTI Clinical Trial and Consulting Services adds 2 to clinical department

COVINGTON, Ky. (April 23, 2018) — CTI Clinical Trial and Consulting Services (CTI), a multi-national, privately held, full-service contract research organization has hired Stuart Byham and Adam Roth to the Clinical Operations and Clinical Research Center departments, respectively. “We are thrilled to welcome Stuart and Adam to CTI,” said Kevin Schwarz, CTI’s chief operating officer. “Their expertise […]

University of Texas System Initiative, Clinical Trials Xpress (CTX), Named as a PAREXEL Strategic Site Alliance …

University of Texas System Initiative, Clinical Trials Xpress (CTX), Named as a PAREXEL Strategic Site Alliance …

Designed to collaboratively combine and leverage expertise and resources to promote and expedite clinical trials and drug development processes, PAREXEL’s Site Alliance Network includes strategically selected entities that are uniquely suited to enable faster clinical trial recruitment and patient enrollment, avoid trial delays and in turn allow for the rapid advancement and development of new […]

Corvus Pharmaceuticals Announces Initiation of Phase 1/1b Clinical Trial of Investigational Anti-CD73 Antibody, CPI …

Corvus Pharmaceuticals Announces Initiation of Phase 1/1b Clinical Trial of Investigational Anti-CD73 Antibody, CPI …

BURLINGAME, Calif., April 26, 2018 (GLOBE NEWSWIRE) — Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS), a clinical-stage biopharmaceutical company focused on the development and commercialization of precisely targeted oncology therapies, today announced that it is enrolling patients in a multicenter Phase 1/1b clinical trial of CPI-006, a humanized monoclonal antibody directed against CD73. The three-arm study in patients […]

Flexion Therapeutics (FLXN) Presents Updated Results from Clinical Trial Evaluating Repeat Administration of ZILRETTA

Flexion Therapeutics (FLXN) Presents Updated Results from Clinical Trial Evaluating Repeat Administration of ZILRETTA

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here. Flexion Therapeutics, Inc. (Nasdaq: FLXN) today announced updated interim findings from its ongoing Phase 3b, open-label study to evaluate the overall safety and general tolerability of repeat administration of ZILRETTA (triamcinolone acetonide extended-release injectable […]

Novartis app could revolutionise ophthalmic clinical trials

Novartis app could revolutionise ophthalmic clinical trials

Patients will be able to participate in clinical ophthalmology trials from home thanks to a groundbreaking digital app developed by Novartis. The FocalView app, which will enable patients with mobility issues to take part in clinical trials, means researchers can study and collect data about eye diseases regardless of a person’s location. Patients will be […]